Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.49 |
| ▸ | CTSC | P53634 | 5/20 | 0.47 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.47 |
| ▸ | YARS1 | P54577 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CTSH | P09668 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.42 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.42 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 3/20 | 0.41 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.40 |
| ▸ | IL1RN | P18510 | 1/20 | 0.40 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.40 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3064613 | 0.91 | BACE1 (0.45) | NAALAD2CTSCCYP1A2CYP3A4CTSH | |
| SCHEMBL9390903 | 0.90 | CTSC (0.59) | NAALAD2CTSCSLC7A5CYP1A2CYP3A4 | |
| SCHEMBL890405 | 0.86 | CTSC (0.57) | CTSCSLC7A5YARS1CYP1A2CYP3A4 | |
| SCHEMBL890404 | 0.86 | CTSC (0.57) | CTSCSLC7A5YARS1CYP1A2CYP3A4 | |
| SCHEMBL5150941 | 0.85 | NAALAD2 (0.46) | NAALAD2CTSCCYP1A2CYP3A4CTSH | |
| SCHEMBL8893265 | 0.84 | CTSC (0.67) | CTSCSLC7A5YARS1CYP1A2CYP3A4 | |
| SCHEMBL5996736 | 0.84 | CTSC (0.67) | CTSCSLC7A5YARS1CYP1A2CYP3A4 | |
| SCHEMBL9143188 | 0.84 | CTSC (0.67) | CTSCSLC7A5YARS1CYP1A2CYP3A4 | |
| SCHEMBL9293695 | 0.84 | CTSC (0.67) | CTSCSLC7A5YARS1CYP1A2CYP3A4 | |
| SCHEMBL516225 | 0.84 | CTSC (0.48) | CTSCSLC7A5YARS1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110166063-A1 | POLYMER CONJUGATES OF THERAPEUTIC PEPTIDES | NEKTAR THERAPEUTICS (US) | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166063-A1 | POLYMER CONJUGATES OF THERAPEUTIC PEPTIDES | NGLY1, CD44, IAPP | NAALAD2 654/4885CTSC 331/4885SLC7A5 419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.